Company CellSource Co., Ltd.

Equities

4880

JP3423580004

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for CellSource Co., Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
1,522 ^JPY	+0.33%		+3.75%	+19.00%

2023	Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.	CI
2023	MEDERI Inc. announced that it has received funding from CellSource Co., Ltd.	CI

CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Number of employees: 151

JPY in Million	2022	Weight	2023	Weight	Delta
Contract Processing Services 69.8 %	2,776	65.0 %	3,146	69.8 %	+13.34%
Medical Equipment 15.6 %	670	15.7 %	705	15.6 %	+5.16%
Consulting Services 9.6 %	356	8.3 %	435	9.6 %	+22.13%
Cosmetics and Others 5.0 %	471	11.0 %	224	5.0 %	-52.41%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	4,274	100.0 %	4,511	100.0 %	+5.54%

Managers	Title	Age	Since
Masato Tsumamoto FOU	Founder	41	15-11-29
Takashi Sawada CEO	Chief Executive Officer	66	22-01-26
Takeshi Amemiya BRD	Director/Board Member	61	17-05-31
Yujiro Sugi PRN	Corporate Officer/Principal	40	22-01-31
Katsuji Onishi PRN	Corporate Officer/Principal	53	17-12-31
Hirohiko Hanaki PRN	Corporate Officer/Principal	55	16-08-31

Members of the board	Title	Age	Since
Takashi Sawada CEO	Chief Executive Officer	66	22-01-26
Norio Murakami BRD	Director/Board Member	77	17-09-30
Takeshi Amemiya BRD	Director/Board Member	61	17-05-31
Kumi Fujisawa BRD	Director/Board Member	57	20-12-31
Masato Tsumamoto FOU	Founder	41	15-11-29
Masayuki Yamakawa FOU	Founder	-	15-11-29
Hirohiko Hanaki PRN	Corporate Officer/Principal	55	16-08-31
Tsuneyasu Ozaki BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	19,806,100	9,203,825 ( 46.47 %)	575 ( 0.002903 %)	46.47 %

Name	Equities	%	Valuation
Masayuki Yamakawa 36.22 %	7,173,900	36.22 %	68 M ¥
Serial Incubate KK 9.597 %	1,900,800	9.597 %	18 M ¥
Masato Tsumamoto 6.846 %	1,356,000	6.846 %	13 M ¥
Atlantis Investment Research Corp. 0.8230 %	163,000	0.8230 %	2 M ¥
Hirohiko Hanaki 0.3635 %	72,000	0.3635 %	687 436 ¥
Takeshi Amemiya 0.3166 %	62,700	0.3166 %	598 642 ¥
Jackson National Asset Management LLC 0.2848 %	56,400	0.2848 %	538 491 ¥
SBI Asset Management Co., Ltd. 0.2550 %	50,500	0.2550 %	482 160 ¥
Chibagin Asset Management Co. Ltd. 0.2227 %	44,100	0.2227 %	421 054 ¥
SBI Okasan Asset Management Co. Ltd. 0.1767 %	35,000	0.1767 %	334 170 ¥

Name	Equities	%	Valuation
CUORIPS INC. 0.25%	20,000	0.25%	488,288 $

CellSource Co., Ltd.

Shibuya Mitake Building, 2/F 1-19-5 Shibuya

150-0002, Tokyo

http://www.cellsource.co.jp

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
CELLSOURCE CO., LTD.	+19.00%	193M
SONIC HEALTHCARE LIMITED	-17.89%	8.36B
RADNET, INC.	+40.49%	3.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-32.64%	2.73B
SYNLAB AG	-7.88%	2.47B
DR. LAL PATHLABS LIMITED	-7.35%	2.32B
NEOGENOMICS, INC.	-14.40%	1.77B
FLEURY S.A.	-18.74%	1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.19%	1.22B
METROPOLIS HEALTHCARE LIMITED	+5.57%	1.09B

Medical & Diagnostic Laboratories